Doctor checking data

See clearly. Treat optimally.

Thank you for joining ECIO 2023 in Stockholm! It has been great to connect with you at our booth or during our symposium, hosted by Prof. Hicham Kobeiter.

    Watch our symposium on-demand

    Advancing procedures in aortic

    Impact of navigation tools and advanced imaging on patient outcomes

    Sunday, April 16th | 12:50-13:15 -​ CET |
    Main Auditorium

    Speaker: Prof. Hicham Kobeiter, Hôpital Henri Mondor, Paris, France

    Explore our solutions presented on-booth

    Simplified and advanced 3D imaging with Azurion and SmartCT

    Azurion with SmartCT

    Planning and live guidance with Onco suite

    Onco suite

    World’s first Spectral detector Angio-CT

    Optimizing dissection detection

    * Not available for sale in some geographies, please reach out to your Philips representative for products and services in your area.

    Image fusion and needle navigation

    Infographic desktop image

    Pre-procedural

    Pre procedural thumbnail

    CT Liver and 3D Modeling in IntelliSpace Portal
    Access advanced visualization software from anywhere across the Enterprise to design the treatment strategy, using advanced tools such as automated organ and tumor segmentation and quantification, volumetric multimodal fusion and tumor characterization.

    Use pre-procedural CT and MR images to create a fused multimodal volumetric model of the liver*

    * Not intended for diagnostic use

    Ablation procedures with XperGuide Ablation*

    Xperguide thumbnail

    XperGuide Ablation provides comprehensive assistance for treatment planning and live needle guidance. It offers unique Parallax Correction to plan needle trajectories for off-center lesions [3]. It provides highly accurate live image guidance of each needle to a targeted position by overlaying pre-planned trajectories with fluoroscopic imaging [4]

    * XperGuide Ablation is an option of XperGuide

    TACE procedures with EmboGuide

    Emboguide thumbnail

    EmboGuide supports you in maximizing the efficacy of your TACE procedures as it potentially enhances your sensitivity, reduces false positives and maximizes inter-reader agreement [1]. It provides efficient, workflow-based live 3D guidance with automatic feeder detection [2].​

    Post-procedural

    Post procedural thumbnail

    Multimodality Tumor Tracking in IntelliSpace Portal​

    Compare pre- and post-procedural images to assess early treatment response, and use selected imaging biomarkers from multiple modalities to follow-up the patient over time. qEASL is particularly useful to evaluate changes in tumor volume and enhancement. [5]​

    Use one-click lesion segmentation and propagation algorithm to assess the treatment response.

    1. Chiaradia et al, J J,Sensitivity and Reproducibility of AFD Software for HCC, VascIntervRadiol2018;29:425-431.
    2. Miyayama S, et al.Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheterarterial chemoembolization. J VascIntervRadiol. 2013; 24(4):501-8.
    3. Abi-jaoudeh et al , Cone Beam vs Conventional CT Navigation for Image-Guided Biopsy, J VascIntervRadio; 2016; 27: 1342–1349.
    4. Ji Yung Choo, Percutaneous transthoracic needle biopsy of small (1 cm) lung nodules under C-arm cone-beam CT virtual navigation guidance; EurRadiol; 2013; 23:712–719; 23:712–719.

    5. Wu et al, Cost-effectiveness of imaging tumor response criteria in hepatocellular cancer after transarterial chemoembolization. J Am Coll Radiol 2021

    We are always interested in engaging with you.

    Let us know how we can help.

    1
    Select your area of interest
    2
    Contact details

    You are about to visit a Philips global content page

    Continue

    You are about to visit a Philips global content page

    Continue

    Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

    You are entering a Philips Healthcare Australia website
    Please select the checkbox

    The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

    By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.